A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

• Status: Completed
• Trial end date: 2021-02-28
• Target enrollment: 0
• Participant gender: All

Summary

Clinical trial to compare sublingual low does thimerosal in adults that have symptoms of SARS-CoV-2 Infection against placebo to show a difference in physical characteristics and viral levels.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beech Tree Labs, Inc.
• Collaborators: Curavit Clinical Research; Norwich Clinical Research Associates Ltd.

Criteria

Inclusion Criteria:

• 40 years of age or older

• Provide written informed consent

• Have a SARS-COV-19 diagnostic test with positive results

Exclusion Criteria:

• Having an oxygen saturation level below 92% at baseline or currently on Oxygen therapy

• Subjects currently hospitalized

• Subjects who have received a COVID vaccination

• Subjects with a diagnosis of immunodeficiency